:format(jpeg)/cloudfront-us-east-1.images.arcpublishing.com/gfrmedia/PH7JVG5MGVGNPAWAFKVSEZPCPE.jpg)
A team of Spanish researchers has managed to identify a series of genetic mutations that are associated with greater severity of the Covid-19 among men, and especially among those over 60 years of age.
Researchers have shown that there are a series of genetic variants that influence the evolution of Covid-19 in men and women and have identified a series of mutations associated with a greater severity of the disease in men.
The study, which can facilitate the understanding of possible complications associated with this disease, is part of the international project Scourge, in which institutions from Spain and Latin America participate, and this study has focused on patients from 34 Spanish hospitals recruited between March and December 2020.
The authors, belonging to several networked biomedical research centers (CIBER) of the Carlos III Health Institute, have studied the genome of 11,939 COVID cases from all over Spain for two years with extensive clinical information on the affected people.
This study has also included samples and clinical data collected in the Stop Coronavirus project, also funded by the Covid-19 Fund of the Carlos III Health Institute and led by Jose Maria Aguado, from the 12 de Octubre Hospital in Madrid, in which they have also Other Spanish hospitals participated, and the results have been published in the journal Human Molecular Genetics.
After carrying out association studies of genomic markers based on sex in hospitalized people, the authors have identified variants in several genes (TLR7 and IFN, among others) that confirm their role in the evolution of the disease, reported the Carlos Health Institute. III in a note released today.
For example, certain mutations linked to the X chromosome (in the TLR7 gene) are the cause of a type of Covid-19 associated with high mortality that only affects men.
Researchers from the Carlos III Health Institute have also published the results of another study, which is part of the CIBERES-UCI-COVID project to deepen the knowledge of the effects of the use of corticosteroids in patients affected by covid-19 and admitted to the intensive care unit.
In this case, scientists have looked for variables that can better guide personalized treatment with these medications, and have proven that corticosteroids are effective in improving survival, but must be administered depending on age, severity, baseline inflammation and ventilation. invasive mechanics.
They have warned of the special relevance of the finding in which researchers have shown that early use of steroids – 7 days or less from the onset of symptoms – can be harmful to patients.
These results are based on the analysis, between February 2020 and October 2021, of 4,226 patients admitted to 55 Spanish ICUs, the majority of whom (85 percent) were treated with corticosteroids during hospitalization.
The results have been published in the journal Intensive Care Medicine and conclude that corticosteroids were, overall, effective in reducing 90-day mortality and in-hospital mortality, and that the level of effectiveness of the use of steroids varied depending on the factors studied, which is why they have suggested the importance of personalizing the use of this type of drugs.
